Magnetar Financial LLC Takes Position in Danaher Corporation $DHR

Key Points

• Magnetar Financial LLC has made a new investment in Danaher Corporation, purchasing 27,607 shares valued at approximately $5.66 million during the first quarter.
• Institutional investors hold a significant portion of Danaher’s stock, with 79.05% owned by hedge funds and institutions, indicating strong confidence in the company.
• Danaher reported a quarterly revenue of $5.94 billion with an adjusted EPS of $1.80, exceeding analysts' expectations and reflecting a 3.4% increase year-over-year.

Magnetar Financial LLC bought a new position in shares of Danaher Corporation (NYSE:DHR - Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 27,607 shares of the conglomerate's stock, valued at approximately $5,659,000.

A number of other institutional investors and hedge funds have also recently made changes to their positions in DHR. MGO One Seven LLC grew its position in Danaher by 485.7% in the first quarter. MGO One Seven LLC now owns 25,098 shares of the conglomerate's stock valued at $5,145,000 after acquiring an additional 20,813 shares during the last quarter. Asahi Life Asset Management CO. LTD. bought a new position in Danaher in the first quarter valued at about $539,000. Horizon Financial Services LLC grew its position in Danaher by 20,400.0% in the first quarter. Horizon Financial Services LLC now owns 8,200 shares of the conglomerate's stock valued at $1,681,000 after acquiring an additional 8,160 shares during the last quarter. Texas Capital Bank Wealth Management Services Inc grew its position in Danaher by 6.1% in the first quarter. Texas Capital Bank Wealth Management Services Inc now owns 34,763 shares of the conglomerate's stock valued at $7,126,000 after acquiring an additional 2,009 shares during the last quarter. Finally, EFG Asset Management Americas Corp. grew its holdings in shares of Danaher by 13.1% during the first quarter. EFG Asset Management Americas Corp. now owns 36,080 shares of the conglomerate's stock worth $7,396,000 after purchasing an additional 4,191 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company's stock.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on DHR. Robert W. Baird boosted their price target on Danaher from $225.00 to $226.00 and gave the stock an "outperform" rating in a report on Friday, July 18th. Guggenheim reissued a "buy" rating and issued a $250.00 price target on shares of Danaher in a research note on Wednesday, July 23rd. Evercore ISI lowered their target price on Danaher from $230.00 to $226.00 and set an "outperform" rating on the stock in a research report on Tuesday, July 8th. Barclays reissued an "overweight" rating and issued a $225.00 price target (up from $215.00) on shares of Danaher in a research report on Tuesday, June 24th. Finally, Wells Fargo & Company reduced their price objective on Danaher from $210.00 to $205.00 and set an "equal weight" rating for the company in a research note on Wednesday, July 23rd. Seventeen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $247.61.

Insider Transactions at Danaher

In other news, Director Teri List sold 2,778 shares of Danaher stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the sale, the director directly owned 20,751 shares in the company, valued at approximately $4,379,706.06. This trade represents a 11.81% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 11.20% of the stock is currently owned by insiders.

Danaher Price Performance

Shares of NYSE DHR traded down $2.02 during trading hours on Tuesday, reaching $203.80. 2,388,966 shares of the stock traded hands, compared to its average volume of 4,161,300. The company has a market capitalization of $145.93 billion, a P/E ratio of 43.36, a price-to-earnings-growth ratio of 2.87 and a beta of 0.75. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $279.90. The company's 50-day simple moving average is $201.84 and its two-hundred day simple moving average is $199.46.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, beating analysts' consensus estimates of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The company had revenue of $5.94 billion for the quarter, compared to analysts' expectations of $5.83 billion. During the same period last year, the firm posted $1.72 EPS. Danaher's revenue for the quarter was up 3.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Equities research analysts forecast that Danaher Corporation will post 7.63 EPS for the current year.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.